Literature DB >> 9430022

Regression of superficial gastric MALT lymphoma with unsuccessful eradication therapy for Helicobacter pylori infection.

H Yoshikane1, T Yokoi, H Hidano, A Sakakibara, Y Niwa, H Goto.   

Abstract

A 51-year-old man had a reddish flat granular lesion in the stomach on endoscopic examination. Histology of biopsied specimen confirmed the diagnosis of low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue (gastric MALT lymphoma) and simultaneous infection with Helicobacter pylori. He was given antibiotic treatment. Five weeks later, endoscopy and histology of biopsied specimen showed eradication of H. pylori, and the tumor had regressed. Six months later, H. pylori reemerged, but the tumor had not recurred. After the second antibiotic therapy, H. pylori has been eradicated. The lymphoma has been in remission for 14 months.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9430022     DOI: 10.1007/bf02936960

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  12 in total

1.  Helicobacter pylori reinfection and rapid relapse of low-grade B-cell gastric lymphoma.

Authors:  G Cammarota; M Montalto; A Tursi; F M Vecchio; G Fedeli; G Gasbarrini
Journal:  Lancet       Date:  1995-01-21       Impact factor: 79.321

2.  Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment.

Authors:  E A Rauws; W Langenberg; H J Houthoff; H C Zanen; G N Tytgat
Journal:  Gastroenterology       Date:  1988-01       Impact factor: 22.682

3.  Relapse of MALT lymphoma associated with Helicobacter pylori after antibiotic treatment.

Authors:  M Horstmann; R Erttmann; K Winkler
Journal:  Lancet       Date:  1994-04-30       Impact factor: 79.321

4.  Lymphoid follicles in antral mucosa: immune response to Campylobacter pylori?

Authors:  M Stolte; S Eidt
Journal:  J Clin Pathol       Date:  1989-12       Impact factor: 3.411

5.  Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori.

Authors:  A C Wotherspoon; C Doglioni; T C Diss; L Pan; A Moschini; M de Boni; P G Isaacson
Journal:  Lancet       Date:  1993-09-04       Impact factor: 79.321

6.  The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori.

Authors:  T Hussell; P G Isaacson; J E Crabtree; J Spencer
Journal:  Lancet       Date:  1993-09-04       Impact factor: 79.321

7.  Immune response of the gastric mucosa to Campylobacter pylori.

Authors:  J I Wyatt; B J Rathbone
Journal:  Scand J Gastroenterol Suppl       Date:  1988

8.  Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group.

Authors:  E Bayerdörffer; A Neubauer; B Rudolph; C Thiede; N Lehn; S Eidt; M Stolte
Journal:  Lancet       Date:  1995-06-24       Impact factor: 79.321

9.  Gastric lymphoid follicles in Helicobacter pylori infection: frequency, distribution, and response to triple therapy.

Authors:  R M Genta; H W Hamner; D Y Graham
Journal:  Hum Pathol       Date:  1993-06       Impact factor: 3.466

10.  Factors influencing lymph node infiltration in primary gastric malignant lymphoma of the mucosa-associated lymphoid tissue.

Authors:  S Eidt; M Stolte; R Fischer
Journal:  Pathol Res Pract       Date:  1994-11       Impact factor: 3.250

View more
  2 in total

1.  Disappearance of rectal mucosa-associated lymphoid tissue lymphoma following antibiotic therapy.

Authors:  Kazutoshi Hori; Motohiko Suguro; Hiromasa Koizuka; Takashi Sakagami; Toshihiko Tomita; Tadashi Kosaka; Yoshihiro Fukuda
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

2.  Gastritis staging in clinical practice: the OLGA staging system.

Authors:  Massimo Rugge; Alberto Meggio; Gianmaria Pennelli; Francesco Piscioli; Luciano Giacomelli; Giovanni De Pretis; David Y Graham
Journal:  Gut       Date:  2006-12-01       Impact factor: 23.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.